رمز بسيط، تكوّن من سلسلة روابط مُحاطة بدائرة، وهي رمز شائع للاتصال أو الارتباط التشعبي. تم تحديد خطوط الأيقونة بلون أسود داكن على الخلفية، مع إضافة عناصر عسكرية من الهوية الوطنية السعودية مثل الغترة والشماع والبشت السعودي، لتعكس الطابعة المحلية المميزة لجامعة القصيم.
روابط المواقع الالكترونية الرسمية التعليمية السعودية تنتهي بـ edu.sa
جميع روابط المواقع الرسمية التعليمية التابعة للجهات الحكومية في المملكة العربية السعودية تنتهي بـ .edu.sa
علامة لفتة سوداء اللون من الجلد البسيط، قبضة بدائرة سوداء، يعلوها رسم واضحي لغترة سعودية مع شماع وعقال، تبرز معالم البشت السعودي في. يرمز هذا التصميم إلى مفهوم الأمان وخصوصية البيانات الرقمية يعكس هوية جامعة القصيم.
المواقع الالكترونية الحكومية تستخدم بروتوكول HTTPS للتشفير و الأمان.
المواقع الالكترونية الآمنة في المملكة العربية السعودية تستخدم بروتوكول HTTPS للتشفير.
هيئة الحكومة الرقمية

أعضاء هيئة التدريس

المحتوى

يرتدي رجل يرتدي زيًا أبيض تقليديًا مع شماغ سعودي أحمر وأبيض داخل أحد المباني، مسجون في الكاميرا بتعبير حيادي كما لو كان يلتقط صورة لملف أعضاء هيئة التدريس في جامعة القصيم.
صورة عضو هيئة التدريس

بدر ابراهيم على الشمسان

أستاذ مشارك
كلية الطب،
قسم الباطنة

البيانات الشخصية

    المؤهلات العلمية

      الاهتمامات البحثية

      • medicine
      • oncology
      • academic_qualifications

      الأبحاث المنشورة

      • Temozolomide chronotherapy in glioma: a systematic review (2023-01-01)
      • Regularly scheduled physical examinations and the detection of breast cancer recurrences (2023-01-01)
      • Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer (2024-01-01)
      • Gastrointestinal stromal tumors: 10-year experience in cancer center—the Ottawa Hospital (TOH) (2022-01-01)
      • Trends of cancer incidence in Qassim Region, a descriptive analysis of data from the Saudi Cancer registry 2002–2016 (2022-01-01)
      • New onset refractory status epilepticus due to primary angiitis of the central nervous system (2017-01-01)
      • Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers (2022-01-01)
      • Real-world outcome and prognostic factors of pazopanib in advanced soft tissue sarcoma (2021-01-01)
      • Evaluation of problem based learning course at college of medicine, Qassim University, Saudi Arabia (2009-01-01)
      • Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi Arabia (2023-01-01)
      • Vascular access types in patients starting hemodialysis after failed kidney transplant: does close nephrology follow-up matter? (2017-01-01)
      • Metastasectomy in synovial sarcoma: A systematic review and meta-analysis (2022-01-01)
      • Perceptions and attitudes of medical oncologists regarding fertility preservation and pregnancy in high‐risk cancer patients: A survey among Canadian medical oncologists (2023-01-01)
      • Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review (2022-01-01)
      • Durable response to pazopanib in recurrent metastatic carotid body paraganglioma (2021-01-01)
      • Association between obesity and clinicopathological profile of patients with newly diagnosed non-metastatic breast cancer in Saudi Arabia (2022-01-01)
      • Assessing frequency and clinical outcomes of BRCA mutated ovarian cancer in Saudi women (2022-01-01)
      • Metastasectomy in leiomyosarcoma: A systematic review and pooled survival analysis (2022-01-01)
      • Organizing pneumonia secondary to cetuximab in a patient with colorectal cancer (2019-01-01)
      • Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre (2023-01-01)
      • Real world evidence of outcomes and treatment patterns for advanced biliary tract cancer in Saudi Arabia (2025-07-16)
      • Real-world clinical outcome of unresectable locally advanced & de-novo metastatic pancreatic ductal adenocarcinoma: a multicentre retrospective study (2025-01-03)
      • Characteristics and Outcomes of Soft Tissue Sarcoma in Saudi Arabia: A 10-Year Experience (2025-01-01)
      • Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review (2022-08-22)
      • Perception of pneumocystis jirovecii pneumonia (PJP) prophylaxis in glioma patients receiving concurrent temozolomide and radiation- a patient and physician survey (2024-08-06)
      • Neutrophil-to-lymphocyte ratio as a prognostic factor for neoadjuvant chemotherapy for locally advanced breast cancer (2020-09-01)
      • Pazopanib treatment outcome in advanced soft tissue sarcoma: Real-world data (2020-09-01)
      • Efficacy and tolerability of cetuximab 750 mg/m<SUP>2</SUP> every three weeks in metastatic colorectal cancer (2023-07-01)
      • Characteristic and clinical outcome of localized gastric cancer; real-world data (2023-07-01)
      • Regularly scheduled physical examinations and the detection of breast cancer recurrences (2023-03-15)
      • Metastasectomy in synovial sarcoma: A systematic review and metaanalysis (2022-09-26)
      • Capecitabine Monotherapy as Palliative Treatment for Patients with Recurrent/Metastatic Nasopharyngeal Cancer (2022-04-05)
      • Assessing frequency and clinical outcomes of <i>BRCA</i> mutated ovarian cancer in Saudi women (2022-01-03)
      • Characteristics and treatment results of patients with gastroenteropancreatic neuroendocrine tumors in a tertiary care centre (2023-04-07)
      • Insights into the Refusal of Free Screening Mammograms: Exploring Contributing Factors (2024-01-01)
      • Association Between Obesity and Clinicopathological Profile of Patients with Newly Diagnosed Non-Metastatic Breast Cancer in Saudi Arabia (2022-01-01)
      • Metastasectomy in Leiomyosarcoma: A Systematic Review and Pooled Survival Analysis (2022-07-01)
      • Gastrointestinal Stromal Tumors: 10-Year Experience in Cancer Center-The Ottawa Hospital (TOH) (2022-10-01)
      • Integrating Systematic Reviews into Supportive Care Trial Design: The Rethinking Clinical Trials (REaCT) Program (2022-12-01)
      • Temozolomide Chronotherapy in Glioma: A Systematic Review (2023-02-01)
      • Prognostic significance of the neutrophil to lymphocyte ratio in locally advanced breast cancer (2024-09-01)
      • Triple-M Overlap Syndrome Associated with Immune Checkpoint Inhibitors: A FAERS Pharmacovigilance Analysis (2026-06-16)
      • Conversion and resection rates in borderline resectable and locally advanced pancreatic cancer following neoadjuvant therapy: a retrospective multicenter cohort study (2026-06-07)
      • Treatment patterns and outcomes in high-risk WHO grade 2 diffuse glioma: a multicentre retrospective cohort study (2026-05-27)
      • Colorectal cancer awareness and acceptance of fecal immunochemical test screening in Qassim, Saudi Arabia (2026-02-10)
      • Complementary and Alternative Therapy Use Among Cancer Patients in Qassim: Patterns, Predictors, and Patient Perspectives (2026-01-24)
      • Pneumocystis jirovecii pneumonia prophylaxis in patients with glioma receiving concurrent chemoradiation: a systematic review and meta-analysis (2026-01-11)
      • Real-world clinical outcomes of locally advanced unresectable and de-novo metastatic pancreatic ductal adenocarcinoma: A multicenter retrospective study from Saudi Arabia. (2025-02-18)
      • Resectability rate of pancreatic cancer after neoadjuvant therapy (2024-08-18)
      • Outcome and prognostic factors of low-grade serous ovarian cancers: an observational retrospective study (2025-03-21)
      • THERABIOME-GBM: THERAPEUTIC OUTCOMES RELATED TO GUT MICROBIOME IN GLIOBLASTOMA (GBM) PATIENTS RECEIVING CHEMO-RADIATION: A PROSPECTIVE OBSERVATIONAL STUDY (2024-02-12)
      • Does reducing the frequency of regularly scheduled physical examinations affect recurrence detection in patients with early breast cancer? (2023-08-27)
      • PROTECT: PROCARBAZINE, LOMUSTINE, AND VINCRISTINE VERSUS TEMOZOLAMIDE IN HIGH-RISK, LOW-GRADE GLIOMAS: A RETROSPECTIVE COHORT STUDY (2022-12-23)
      • Will COVID-19 directives to reduce regularly scheduled physical examinations affect recurrence detection in patients with early breast cancer? (2022-11-03)
      • Second primary malignancies (SPM) in patients with gastrointestinal stromal tumors (GIST): 10-year experience from the Ottawa Hospital (TOH). (2022-11-03)
      • Characteristics and outcomes of soft tissue sarcoma in Saudi Arabia. (2022-11-03)
      • Metastasectomy in synovial sarcoma: A systematic review. (2022-11-03)
      • Perceptions and attitudes of medical oncologists regarding fertility preservation and pregnancy in high-risk cancer patients: A survey among Canadian medical oncologists (2022-07-19)
      • Symptomatic skeletal-related events in patients receiving longer term bone-modifying agents for bone metastases from breast and castration resistant prostate cancers (2022-01-27)
      • Patient's characteristics and outcome of small bowel adenocarcinoma in Saudi Arabia. (2021-11-25)
      • Metaplastic breast cancer: Disease characteristics and outcome in Arab women. (2021-11-25)
      • Capecitabine therapy in recurrent/metastatic nasopharyngeal cancers. (2021-03-03)
      • The outcome of vincristine, dactinomycin D, ifosfamide and doxorubicin (VAIA) as first-line therapy for adult-patients with metastatic ewing sarcoma; a single-center experience. (2021-03-03)
      • Association between obesity and the clinical stage of newly diagnosed breast cancer: Experience with 2212 patients. (2020-10-09)
      • Colorectal cancer incidence in Saudi Arabia, 2002-2023: Age-specific trends and implications for screening and prevention (2026-06-05)
      • Quality of Life and Its Psychosocial Determinants Among Cancer Patients: Insights from the Qassim Region, Saudi Arabia (2026-04-20)
      • Cancer Patients' Experiences and Management of Chemotherapy-Induced Peripheral Neuropathy: A Qualitative Study in Qassim, Saudi Arabia (2026-04-18)
      • Insights into the prognostic significance of cell division cycle 25A (CDC25A) in breast cancer (2026-04-10)
      • Survival outcomes and prognostic factors in <i>de novo</i> advanced biliary tract cancer: insights from a Saudi multicenter cohort (2026-07-18)

      المواد التدريسية

      • MED411-12 الطب الباطني
      • MED 341 مهارات الفحص السريري

      ملفات تعريف الارتباط

      هذا الموقع يستخدم ملفات تعريف الارتباط الخاصة لضمان سهولة الاستخدام، وتحسين تجربتك أثناء التصفح، كما يوضح الأحكام والسياسات المتعلقة بخصوصية المستخدم. من خلال الاستمرار في تصفح هذا الموقع، فإنك تقر بقبول استخدام ملفات تعريف الارتباط، وما جاء في سياسة الخصوصية